Hedge Fund - DAFNA Capital Management
Cytokinetics Inc (CYTK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $33,396,000 | 8% | 400,000 | $36.21 |
| 2 | 2023 - Q3 (2023-09-30) | $14,127,189 | 4.39% | 479,538 | $33.30 |
| 3 | 2023 - Q2 (2023-06-30) | $10,853,783 | 2.96% | 332,734 | $37.00 |
| 4 | 2023 - Q1 (2023-03-31) | $9,729,859 | 2.91% | 276,495 | $40.80 |
| 5 | 2022 - Q4 (2022-12-31) | $8,430,651 | 2.37% | 183,995 | $42.95 |
| 6 | 2022 - Q3 (2022-09-30) | $8,915,000 | 2.39% | 183,995 | $48.13 |
| 7 | 2022 - Q2 (2022-06-30) | $8,310,000 | 2.26% | 211,495 | $40.26 |
| 8 | 2022 - Q1 (2022-03-31) | $7,785,000 | 2.02% | 211,495 | $35.53 |
| 9 | 2021 - Q4 (2021-12-31) | $6,112,000 | 1.53% | 134,094 | $38.59 |
| 10 | 2021 - Q3 (2021-09-30) | $6,255,000 | 1.65% | 175,000 | $29.44 |
| 11 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $12.76 |
| 12 | 2019 - Q4 (2019-12-31) | $4,443,000 | 1.52% | 418,727 | $10.27 |
| 13 | 2019 - Q3 (2019-09-30) | $4,765,000 | 1.79% | 418,727 | $12.55 |
| 14 | 2019 - Q2 (2019-06-30) | $5,368,000 | 2.01% | 477,196 | $9.64 |
| 15 | 2019 - Q1 (2019-03-31) | $3,238,000 | 1.39% | 400,294 | $7.35 |
| 16 | 2018 - Q4 (2018-12-31) | $1,174,000 | 0.58% | 185,826 | $7.34 |
| 17 | 2018 - Q3 (2018-09-30) | $617,000 | 0.25% | 62,690 | $8.02 |
| 18 | 2018 - Q2 (2018-06-30) | $576,000 | 0.26% | 69,437 | $8.32 |
| 19 | 2017 - Q1 (2017-03-31) | $0 | 0% | 0 | $11.69 |
| 20 | 2016 - Q4 (2016-12-31) | $2,555,000 | 2.24% | 210,306 | $10.61 |
| 21 | 2016 - Q3 (2016-09-30) | $1,668,000 | 1.16% | 181,737 | $10.44 |
| 22 | 2016 - Q2 (2016-06-30) | $1,424,000 | 1.12% | 150,000 | $8.21 |
| 23 | 2016 - Q1 (2016-03-31) | $392,000 | 0.33% | 55,600 | $7.31 |
| 24 | 2015 - Q4 (2015-12-31) | $418,000 | 0.37% | 40,000 | $9.81 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:6.0000 on 2013-06-25